San Francisco-based Pax Labs,
which makes app-controlled vaporization technologies and devices
for cannabis flowers and concentrates, announced Friday
agreements with leading cannabis companies to leverage its
innovative Era device and platform.
Pax Labs said Aphria Inc (NYSE:
Aurora Cannabis Inc (NYSE: ACB), OrganiGram
Holdings Inc (NASDAQ: OGI) and Supreme
Cannabis Company have signed on as PAX Era brand partners,
which allows these companies to offer their products in pods
compatible with the design-forward PAX Era device. The PAX Era is a
pen-and-pod system for cannabis concentrates.
Pax Labs said the system will be available in
Canada later this year, contingent on changes to the Cannabis Act
in Canada to permit the sale of cannabis extracts for
"We are excited to bring our premium cannabis
extracts from Solei, RIFF and our flagship medical cannabis brand,
Aphria, to the PAX Era device and platform," said Irwin Simon,
interim CEO of Aphria.
Aphria said it plans to introduce PAX pods for
both adult-use consumers and medical patients. Vapes &
Concentrates will represent close to 30 percent of the entire
Canadian adult-use market by 2021, Aphria said.
Meanwhile, Supreme Cannabis said it will deliver
its 7ACRES flower extracted into oils exclusively for use in the
PAX Era device.
Stifel Cautious On Aurora Cannabis Given
'Lack Of A Definitive Strategy' In US
VPR Brands Kevin Frija: Vaping, Cannabis
Industries Are Like 'Orange Juice And Oranges'
Photo courtesy of Pax Labs.
See more from Benzinga
Â© 2019 Benzinga.com. Benzinga does not provide
investment advice. All rights reserved.